Amneal markets a portfolio of branded pharmaceutical products through its Specialty segment, with a primary focus on central nervous system and endocrine disorders, including UNITHROID® (levothyroxine sodium tablets) in the U.S.
UNITHROID has been manufactured in New York for more than 2 decades with no history of recalls, reformulations, or gaps in availability. More than 90% of eligible, commercially insured patients may pay as little as $3 for a 30-day prescription.
Unithroid is not indicated for the treatment of weight loss or obesity. Toxicity may occur if daily hormonal requirement is surpassed.
For additional safety information, including Boxed Warning, visit UnithroidHCP.com.
Pharmaceutical